Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Hodgkin Lymphoma
Regimen:
AEPA-CAPDAC
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
01/12/2023
Excerpt:
Pediatric Hodgkin Lymphoma….PRIMARY TREATMENT...Other Recommended Regimen...AEPA x 2 cycles (HLHR13)...CAPDAC x 4 cycles.
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login